Understanding cancer lineage plasticity: reversing therapeutic resistance in metastatic prostate cancer

被引：7
|
作者：
Ellis, Leigh [1 ,2 ]
机构：
[1] Harvard Med Sch, Dept Oncol Pathol, Dana Farber Canc Inst, Brigham & Womens Hosp, 450 Brookline Ave, Boston, MA 02215 USA
[2] Harvard Med Sch, Dept Pathol, Brigham & Womans Hosp, Boston, MA 02115 USA
来源：
PHARMACOGENOMICS | 2017年 / 18卷 / 07期
关键词：
androgen receptor; castrate-resistant prostate cancer; epigenetic therapy; EZH2; lethal prostate cancer; lineage plasticity; neuroendocrine; prostate cancer metastasis; CIRCULATING TUMOR-CELLS; N-MYC; EVOLUTION;
D O I：
10.2217/pgs-2017-0039
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：597 / 600
页数：4
相关论文
共 50 条
  • [21] Novel Therapeutic Strategies for Metastatic Prostate Cancer in the Post-Docetaxel Setting
    Sartor, Oliver
    Michels, Ross M.
    Massard, Christophe
    de Bono, Johann Sebastian
    ONCOLOGIST, 2011, 16 (11) : 1487 - 1497
  • [22] Prostate luminal cell plasticity and cancer
    Williams, Emily C.
    Shibata, Maho
    CANCER LETTERS, 2025, 611
  • [23] Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
    Jin, Yujuan
    Chen, Yanxu
    Qin, Zhen
    Hu, Liang
    Guo, Chenchen
    Ji, Hongbin
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (06) : 948 - 955
  • [24] Novel signatures of prostate cancer progression and therapeutic resistance
    Wang, Jason
    Ben-David, Reuben
    Mehrazin, Reza
    Yang, Wei
    Tewari, Ashutosh K.
    Kyprianou, Natasha
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2023, 27 (12) : 1195 - 1206
  • [25] Androgen pathway resistance in prostate cancer and therapeutic implications
    Maughan, Benjamin L.
    Antonarakis, Emmanuel S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (10) : 1521 - 1537
  • [26] The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
    Bitting, Rhonda L.
    Schaeffer, Daneen
    Somarelli, Jason A.
    Garcia-Blanco, Mariano A.
    Armstrong, Andrew J.
    CANCER AND METASTASIS REVIEWS, 2014, 33 (2-3) : 441 - 468
  • [27] BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity
    Westaby, Daniel
    Jimenez-Vaca, Juan M.
    Figueiredo, Ines
    Rekowski, Jan
    Pettinger, Claire
    Gurel, Bora
    Lundberg, Arian
    Bogdan, Denisa
    Buroni, Lorenzo
    Neeb, Antje
    Padilha, Ana
    Taylor, Joe
    Zeng, Wanting
    Das, Souvik
    Hobern, Emily
    Riisnaes, Ruth
    Crespo, Mateus
    Miranda, Susana
    Ferreira, Ana
    Hanratty, Brian P.
    Rodrigues, Daniel Nava
    Bertan, Claudia
    Seed, George
    Maza, Maria de Los Dolores Fenor de La
    Guo, Christina
    Carmichael, Juliet
    Grochot, Rafael
    Chandran, Khobe
    Stavridi, Anastasia
    Varkaris, Andreas
    Stylianou, Nataly
    Hollier, Brett G.
    Tunariu, Nina
    Balk, Steven P.
    Carreira, Suzanne
    Yuan, Wei
    Nelson, Peter S.
    Corey, Eva
    Haffner, Michael
    de Bono, Johann
    Sharp, Adam
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (18)
  • [28] The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity
    Storck, William K.
    May, Allison M.
    Westbrook, Thomas C.
    Duan, Zhi
    Morrissey, Colm
    Yates, Joel A.
    Alumkal, Joshi J.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [29] LSD1: A single target to combat lineage plasticity in lethal prostate cancer
    Ellis, Leigh
    Loda, Massimo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (18) : 4530 - 4531
  • [30] Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNA
    Ritch, Elie
    Wyatt, Alexander W.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 380 - 384
12345